Redmile Group’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-582,805
Closed -$10.3M 73
2021
Q4
$10.3M Sell
582,805
-1,922,313
-77% -$34M 0.23% 60
2021
Q3
$52.7M Sell
2,505,118
-287,330
-10% -$6.04M 0.92% 34
2021
Q2
$55.1M Buy
2,792,448
+40,633
+1% +$801K 0.81% 38
2021
Q1
$80M Buy
+2,751,815
New +$80M 1.13% 29